Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TNYA Tenaya Therapeutics Inc

交易中 05-22 14:12:46 EDT

0.7902

+0.0002

+0.03%

最高0.8200	最低0.7840	成交量122.59万
今开0.7913	昨收0.7900	日振幅4.56%
总市值1.71亿	流通市值1.63亿	总股本2.17亿
成交额97.71万	换手率0.60%	流通股本2.06亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TNYA","market":"US","secType":"STK","nameCN":"Tenaya Therapeutics Inc","latestPrice":0.7902,"timestamp":1779473431974,"preClose":0.79,"halted":0,"volume":1225891,"delay":0,"changeRate":0.0002531645569619974,"floatShares":205841252,"shares":216505900,"eps":-0.465978,"marketStatus":"交易中","change":0.0002,"latestTime":"05-22 14:12:46 EDT","open":0.7913,"high":0.82,"low":0.784,"amount":977115.3002714,"amplitude":0.04557,"askPrice":0.7969,"askSize":801,"bidPrice":0.7901,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.465978,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779480000000},"marketStatusCode":2,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.79,"preHourTrading":{"tag":"盘前","latestPrice":0.7901,"preClose":0.79,"latestTime":"09:21 EDT","volume":17132,"amount":13412.4235104,"timestamp":1779456070539,"change":0.0001,"changeRate":0.000127,"amplitude":0.012785},"postHourTrading":{"tag":"盘后","latestPrice":0.7834,"preClose":0.79,"latestTime":"19:50 EDT","volume":165282,"amount":130041.4883,"timestamp":1779407413025,"change":-0.0066,"changeRate":-0.008354,"amplitude":0.037975},"volumeRatio":0.417277,"impliedVol":2.1122,"impliedVolPercentile":0.7171},"requestUrl":"/m/hq/s/TNYA/tweets","defaultTab":"tweets","newsList":[{"id":"1128772341","title":"Tenaya Therapeutics Inc - TN-401不良事件呈无症状性，可自行缓解或对治疗产生应答","url":"https://stock-news.laohu8.com/highlight/detail?id=1128772341","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128772341?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:04","pubTimestamp":1778839484,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc 公布的数据显示，其药物TN-401在临床试验中观察到的不良事件均为无症状性质，并且这些事件最终自行缓解或对相应的治疗干预产生了良好应答。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199972376","title":"Tenaya 公司 Tn-401 药物 Ridge™-1 1B/2 期临床试验队列 1 和 2 中期积极数据：为 PKP2 相关 ARVC 成人患者持续减轻心律失常负担","url":"https://stock-news.laohu8.com/highlight/detail?id=1199972376","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199972376?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:02","pubTimestamp":1778839361,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics 公司公布了其候选药物 Tn-401 在 Ridge™-1 1B/2 期临床试验中，针对 PKP2 基因相关致心律失常性右室心肌病成人患者的最新中期数据。来自队列 1 和队列 2 的初步结果显示，该疗法能够持续、显著地降低患者的心律失常负担。这一积极信号为后续研究奠定了重要基础，也增强了该创新疗法在治疗这一罕见且严重心脏病方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146995051","title":"Tenaya Therapeutics公布2025年第四季度及全年财务业绩并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1146995051","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146995051?lang=zh_cn&edition=full","pubTime":"2026-03-12 04:05","pubTimestamp":1773259522,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc（简称：Tenaya Therapeutics）近日披露了其2025财年第四季度及全年度的财务报告，同时向市场同步了公司最新的业务动态。此次公布的信息涵盖了公司在财务表现和战略推进方面的关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177542029","title":"Tenaya Therapeutics与Alnylam Pharmaceuticals达成研究合作，共同探索心血管疾病治疗新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=1177542029","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177542029?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:36","pubTimestamp":1772717783,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc（简称Tenaya）已与Alnylam Pharmaceuticals（简称Alnylam）正式签署一项研究合作协议。双方将携手致力于识别并验证针对心血管疾病治疗的新型遗传靶点，旨在推动相关疗法研发取得突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4585","BK4139","BK4548","LU0320765992.SGD","LU0882574055.USD","BK4539","TNYA","LU0109394709.USD","BK4588","LU0114720955.EUR","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608203334","title":"Tenaya Therapeutics, Inc.盘中异动 股价大跌5.03%报0.856美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608203334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608203334?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:27","pubTimestamp":1770139665,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时27分，Tenaya Therapeutics, Inc.股票出现异动，股价快速跳水5.03%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗性疗法，解决心脏病的潜在驱动因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401274597a4b736&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401274597a4b736&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TNYA","LENZ","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145036007","title":"Tenaya Therapeutics预计2026年上半年公布Tn-401治疗PKP2相关ARVC的Ridge-1研究一年期队列1数据及早期队列2数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1145036007","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145036007?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:35","pubTimestamp":1767965725,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc宣布，针对PKP2相关致心律失常性右室心肌病（ARVC）的基因疗法Tn-401，其Ridge-1临床研究预计将于2026年上半年公布重要进展。届时将披露队列1患者接受治疗满一年的随访数据，同时公布队列2研究的早期结果。\n该时间规划凸显了公司对推进罕见心脏病创新疗法的承诺。Ridge-1研究数据的陆续出炉，将为评估Tn-401疗法的安全性与有效性提供关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198326862","title":"Tenaya Therapeutics宣布迅速解决并解除对Mypeak-1™ Tn-201基因疗法I期B/II期临床试验的临床监管","url":"https://stock-news.laohu8.com/highlight/detail?id=1198326862","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198326862?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486978,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics宣布迅速解决并解除对Mypeak-1™ Tn-201基因疗法I期B/II期临床试验的临床监管","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187787927","title":"Tenaya Therapeutics Inc：首两名患者在第八周表现出强大的转导能力和Pkp2蛋白水平的显著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1187787927","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187787927?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486939,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc：首两名患者在第八周表现出强大的转导能力和Pkp2蛋白水平的显著增加","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175073936","title":"Tenaya Therapeutics Inc - 在两个患者中观察到显著的心律失常负担减少，随访超过六个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1175073936","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175073936?lang=zh_cn&edition=full","pubTime":"2025-12-12 05:02","pubTimestamp":1765486935,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc - 在两个患者中观察到显著的心律失常负担减少，随访超过六个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164520085","title":"Tenaya Therapeutics Inc - FDA对Tenaya的Mypeak-1试验实施临床停滞 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1164520085","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164520085?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:14","pubTimestamp":1763572481,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc：*FDA对Tenaya的Mypeak-1试验实施临床停滞 - SEC文件*Tenaya Therapeutics Inc - 预计此停滞不会影响TN-201的时间安排 - SEC文件*Tenaya Therapeutics Inc - FDA要求对Tenaya的Mypeak-1试验进行协议修订 - SEC文件*Tenaya Therapeutics Inc - 正在努力解决临床停滞并恢复给药 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518789128","title":"Tenaya Therapeutics(TNYA.US)：2024年Q4财报实现营收0美元，前值为0美元，预期值为100万美元；每股收益为-0.28美元，前值为-0.40美元，预期值为-0.31美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789128","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518789128?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics(TNYA.US)：2024年Q4财报实现营收0美元，前值为0美元，预期值为100万美元；每股收益为-0.28美元，前值为-0.40美元，预期值为-0.31美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153575348","title":"Tenaya Therapeutics 2024年第四季度GAAP每股亏损$0.28，优于预期的$0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=1153575348","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153575348?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:10","pubTimestamp":1741637435,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics报告季度每股亏损$0.28，优于分析师一致预期的$0.31，超出9.68%。与去年同期每股亏损$0.40相比，这一数据增长了30%。以上内容来自Benzinga Earnings专栏，原文如下：Tenaya $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 9.68 percent. This is a 30 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518719812","title":"Tenaya Therapeutics, Inc.股价飙升20.88% 市值涨1771.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518719812?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613505,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Tenaya Therapeutics, Inc.股票出现波动，股价急速拉升20.88%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1916.39%、394.22%、52.01%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213145abf2fc08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213145abf2fc08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517366169","title":"Tenaya Therapeutics, Inc.盘中异动 早盘股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517366169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517366169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271506,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Tenaya Therapeutics, Inc.股票出现波动，股价快速拉升5.98%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为946.46%、104.14%、48.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223146abeb7788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223146abeb7788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910524","title":"Tenaya Therapeutics, Inc.股价上涨17.16% 市值涨700.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910524?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185025,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Tenaya Therapeutics, Inc.股票出现波动，股价大幅拉升17.16%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.54%、251.30%、183.65%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited，振幅分别为8.56%、6.59%、5.61%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223026a260c6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223026a260c6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765668","title":"Tenaya Therapeutics, Inc.盘中异动 下午盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516765668?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:01","pubTimestamp":1741032083,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时01分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下跌5.21%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4574.50%、211.64%、182.38%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040401239637f5c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040401239637f5c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778971","title":"Tenaya Therapeutics, Inc.盘中异动 早盘急速下挫5.86%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778971?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下挫5.86%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为147.60%、62.30%、25.08%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225752a2521ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225752a2521ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513211380","title":"Tenaya Therapeutics, Inc.盘中异动 急速下跌5.29%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513211380?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:07","pubTimestamp":1740164864,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时07分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下挫5.29%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为300.01%、247.92%、136.72%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030745988e17f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030745988e17f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512677671","title":"Tenaya Therapeutics, Inc.盘中异动 股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512677671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512677671?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:04","pubTimestamp":1739898265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时04分，Tenaya Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Aditxt, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为472.65%、183.81%、154.85%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010425a24acd96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010425a24acd96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511769982","title":"Tenaya Therapeutics, Inc.盘中异动 股价大涨5.10%报0.995美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511769982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511769982?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543539,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Tenaya Therapeutics, Inc.股票出现波动，股价急速拉升5.10%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1011.24%、361.73%、330.96%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321998858998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321998858998&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenayatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1551},{"period":"1month","weight":0.14},{"period":"3month","weight":0.2756},{"period":"6month","weight":-0.3577},{"period":"1year","weight":0.7869},{"period":"ytd","weight":0.1103}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tenaya Therapeutics, Inc.于2016年8月在特拉华州注册成立。该公司是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。公司正在从三个不同但相互关联的产品平台推进产品候选：基因治疗、细胞再生和精准医疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.091688},{"month":2,"riseRate":0.2,"avgChangeRate":-0.006231},{"month":3,"riseRate":0.4,"avgChangeRate":-0.077091},{"month":4,"riseRate":0.2,"avgChangeRate":0.069395},{"month":5,"riseRate":0.4,"avgChangeRate":0.024035},{"month":6,"riseRate":0.25,"avgChangeRate":-0.069846},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023292},{"month":8,"riseRate":0.4,"avgChangeRate":0.09529},{"month":9,"riseRate":0.4,"avgChangeRate":-0.101393},{"month":10,"riseRate":0.2,"avgChangeRate":-0.046678},{"month":11,"riseRate":0.4,"avgChangeRate":0.123533},{"month":12,"riseRate":0.2,"avgChangeRate":-0.128991}],"exchange":"NASDAQ","name":"Tenaya Therapeutics Inc","nameEN":"Tenaya Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tenaya Therapeutics Inc(TNYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tenaya Therapeutics Inc,TNYA,Tenaya Therapeutics Inc股票,Tenaya Therapeutics Inc股票老虎,Tenaya Therapeutics Inc股票老虎国际,Tenaya Therapeutics Inc行情,Tenaya Therapeutics Inc股票行情,Tenaya Therapeutics Inc股价,Tenaya Therapeutics Inc股市,Tenaya Therapeutics Inc股票价格,Tenaya Therapeutics Inc股票交易,Tenaya Therapeutics Inc股票购买,Tenaya Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tenaya Therapeutics Inc(TNYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}